We are live on ! Find out more
LPCN icon

Lipocine
LPCN

19 hedge funds and large institutions have $1.65M invested in Lipocine in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

12% more funds holding

Funds holding: 17 → 19 (+2)

0.58% more ownership

Funds ownership: 9.1% → 9.67% (+0.58%)

31% less capital invested

Capital invested by funds: $2.38M → $1.65M (-$729K)

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$54.1K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$18.7K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$17.1K
4
Bank of America
Bank of America
North Carolina
+$9.75K
5
Osaic Holdings
Osaic Holdings
Arizona
+$7.82K

Top Sellers

1
TRCT
Tower Research Capital (TRC)
New York
-$887
2
Morgan Stanley
Morgan Stanley
New York
-$228
3
JP Morgan Chase
JP Morgan Chase
New York
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$720K +$18.7K +4,817 +2%
BlackRock
2
BlackRock
New York
$284K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$187K +$5.3K +1,370 +2%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$124K +$54.1K +13,975 +56%
Renaissance Technologies
5
Renaissance Technologies
New York
$119K +$5.72K +1,478 +4%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$79.3K +$17.1K +4,419 +22%
State Street
7
State Street
Massachusetts
$59.2K – – –
Northern Trust
8
Northern Trust
Illinois
$41.8K – – –
Bank of America
9
Bank of America
North Carolina
$8.21K +$9.75K +2,519 +4,063%
Morgan Stanley
10
Morgan Stanley
New York
$8.19K -$228 -59 -2%
Osaic Holdings
11
Osaic Holdings
Arizona
$7.14K +$7.82K +2,019 +889%
TRCT
12
Tower Research Capital (TRC)
New York
$3.93K -$887 -229 -16%
CSC
13
Caldwell Sutter Capital
California
$1.5K – – –
Fidelity Investments
14
Fidelity Investments
Massachusetts
$754 +$666 +172 +265%
UBS Group
15
UBS Group
Switzerland
$632 +$759 +196 +6,533%
Group One Trading
16
Group One Trading
Illinois
$626 – – –
SS
17
SBI Securities
Japan
$213 +$259 +67 New
T
18
Tidemark
California
$188 +$228 +59 New
JP Morgan Chase
19
JP Morgan Chase
New York
$35 -$4 -1 -8%

LPCN Hedge Fund Activity: Q1 2025 in Review

19 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q1 2025, worth a combined $1.65M — down 31% from $2.38M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new LPCN positions and 0 closed out — a net gain of 2 holders — while 9 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $54.1K. The largest seller was Tower Research Capital (TRC), cutting an estimated $887.

  • 19 institutional investors held Lipocine (LPCN) as of Q1 2025, up from 17 in Q4 2024.
  • Funds reported $1.65M of Lipocine stock for Q1 2025, down 31% quarter-over-quarter.
  • 2 funds opened new Lipocine positions in Q1 2025 and 0 closed out, a net change of +2 holders.
  • The largest Lipocine buyer in Q1 2025 was Susquehanna International Group, an estimated $54.1K added.
  • The largest Lipocine seller in Q1 2025 was Tower Research Capital (TRC), an estimated $887 sold.

Based on aggregated 13F filings for Q1 2025.